Clinical studies recruiting near Neuss

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chr
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07549516 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06830720 A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes
Phase 1 · Profil Institut für Stoffwechselforschung · Eli Lilly and Company · NCT06945406 Change History and Adopt a Robotic SolutioN for anGioplasty procedurE
Phase N/A · Rheinland Klinikum Neuss GmbH · Robocath · NCT05853419 A Three-part First-in-human Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB-UCN2 in H
Phase 1/Phase 2 · PROFIL Institut fuer Stoffwechselforschung GmbH · Gubra A/S · NCT07702890 A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)
Phase 1 · Profil Institut für Stoffwechselforschung · Eli Lilly and Company · NCT06280703 NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High-risk Genetic Alterations
Phase N/A · Research Site · AstraZeneca · NCT06494540 Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for L
Phase 2/Phase 3 · MVZ for oncology and hematology Rhein-Kreis Neuss GmbH · BioNTech SE · NCT06712316 A Single and Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP65
EARLY_Phase 1 · Profil, Institut für Stoffwechselforschung GmbH · Zealand Pharma · NCT07721597 A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Len
Phase 3 · MVZ fuer Haematologie und Onkologie Rhein-Kreis GmbH · Regeneron Pharmaceuticals · NCT06149286 Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated S
Phase 3 · MVZ for oncology and hematology Rhein-Kreis Neuss GmbH · BioNTech SE · NCT06712355 Investigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes
Phase 1 · Profil Institut für Stoffwechselforschung GmbH · Novo Nordisk A/S · NCT07535307 Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State
Phase 1 · Profil Institut · Gan and Lee Pharmaceuticals, USA · NCT07242664 Liom Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM)
NA · Profil for Stoffwechselforschung GmbH · Liom Health AG · NCT06272136 A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-Wor
Phase N/A · MVZ fur Hamatologie und Onkologie Rhein Kreis GmbH · Janssen Research & Development, LLC · NCT07230691 A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesi
Phase 1 · Profil Institut für Stoffwechselforschung GmbH · Novo Nordisk A/S · NCT07578584 BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment
Phase N/A · Medical Care Centre · Pierre Fabre Pharma GmbH · NCT04673955 Enhancing Palliative Care in ICU
NA · Johanna-Etienne Hospital Neuss, Interdisciplinary ICU · Charite University, Berlin, Germany · NCT06605079 A Research Study of a New Medicine, NNC9733-0001, in Healthy Participants and Participants With Type 2 Diabetes
Phase 1 · Profil Institut für Stoffwechselforschung GmbH · Novo Nordisk A/S · NCT07270731 German Registry of Alzheimer's Disease Treated With Transcranial Pulse Stimulation
Phase N/A · Neurologische Praxis Prof. Wojtecki · Heinrich-Heine University, Duesseldorf · NCT06313944 Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting
Phase N/A · Praxis Dres. Plewe/Losem /ID# 202606 · AbbVie · NCT03342144 Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin
Phase 1 · Profil Institut für Stoffwechselforschung GmbH · Sam Chun Dang Pharm. Co. Ltd. · NCT07634770 Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastat
Phase 4 · TZN-Tumorzentrum Niederrhein GmbH · Prof. Wolfgang Janni · NCT05362760 Comparison Study of Insulin GZR4 With Insulin Degludec
Phase 1 · Profil · Gan and Lee Pharmaceuticals, USA · NCT07146347 Comparison of Vessel-FFR Versus FFR in Intermediate Coronary Stenoses
NA · Lukaskrankenhaus Neuss · Helios Health Institute GmbH · NCT03497637 Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)
Phase 3 · Lukaskrankenhaus Neuss · Dominik Paul Modest · NCT05008809 Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell Lymphoma
Phase 3 · Rheinland Klinikum-Lukaskrankenhaus Neuss · Universität des Saarlandes · NCT05820841 A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity
Phase 1 · Profil Institut für Stoffwechselforschung · Eli Lilly and Company · NCT07665879 NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometrial Cancer (DUOLife)
Phase N/A · Research Site · AstraZeneca · NCT06890273

Look up another city

Look up another condition